Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-26

Clinical Trial Update: Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group

View source ↗

Summary

A clinical trial comparing continuous glucose monitoring (CGM) and oral glucose tolerance testing (OGTT) in relation to pancreas T2* MRI-detected iron overload …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Iron Overload, Hemoglobinopathies | Status: WITHDRAWN